Plenary: Predicting Pharmacokinetics/Pharmacodynamics in the Individual Patient: Separating Reality from Hype
Symposium 1: Innovative Scientific & Risk-based Quantitative Approaches to Post-marketing Surveillance of New & Generic Drug Products
Symposium 2: Optimizing Dose/Dosing Frequency for a Biologic: Clinical, Regulatory & Commercial Perspectives
Symposium 3: Master Protocols in Drug Development
Symposium 4: Next Wave in Cancer Medicine: Mechanisms & Progress for Emerging Therapeutics
Symposium 5: Clinical Trial Simulations in Pediatric Drug Development
Symposium 6: Therapeutic Options for Obesity Treatment in Children, Adolescents & Young Adults
Symposium 7: Modeling of Adherence: Applications in Drug Development & Clinical Practice
Symposium 8: Kinase Inhibitors in Pediatric Patients: Experiences, Pharmacology & Future Applications
Symposium 9: What to Do After a Pivotal Trial Has Failed Primary Endpoint Assessment - Totality of Evidence-based Drug Development Challenges & Opportunities
Symposium 10: Challenges & Opportunities in the Development of Inhaled Medicines
Symposium 11: Pioneering NAFLD/NASH Early-phase Clinical Pharmacology Study Designs
Symposium 12: Assessment of Drug Effect on Pediatric Bone Health
Symposium 13: 21st Century HIV/AIDS: An Evolving Drug Development & Technology Paradigm
Symposium 14: Full Extrapolation of Efficacy from Adults to Children of Antiepileptic Drugs Indicated for the Treatment of Partial Onset Seizures
Symposium 15: Biosimilars: An Evolving Science
Symposium 16: Opioid Abuse & Misuse: A Rising Epidemic in America